- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05165758
Comparison of the Quality of Life and the Level of Precarity of a Diabetic Population With and Without Foot Ulcer in Martinique (QVP-Dia)
Study Overview
Status
Intervention / Treatment
Detailed Description
Diabetes is one of the most frequent pathologies in Martinique (French West Indies) in terms of prevalence, as are its complications. The diabetic foot ulcer is a real public health problem considering its impact on the island.
It has already been shown that diabetic patients have a lower quality of life than the overall population. It is now time to compare the quality of life of diabetics with and without foot ulcer in Martinique.
Such a complication has a social impact that should not be overlooked in primary, secondary and tertiary prevention.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Martinique
-
Fort-de-France, Martinique, France, 97261
- University Hospital Center of Martinique
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- People of 18 years old and over,
- Diabetics living in Martinique,
- Patient having been informed of the research,
- Patient agreeing to participate in the study.
Exclusion Criteria:
- Minor patient,
- Hospitalized patients during inclusion phase,
- Patients with confusional syndrome,
- Patient presenting a cognitive state making it difficult to complete the questionnaire,
- Patient under legal protection, under guardianship or under curatorship,
- Patient who refused to participate in the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Diabetic subjects without foot ulcer
27 diabetic subjects without foot ulcer will answer to the SF-36 score (mental health items) and to a french precarit index (EPICES:Evaluation de la précarité et des inégalités de santé dans les Centres d'examens de santé)
|
Subjects will pass the SF-36 score (mental health items) and the EPICES index
|
|
Diabetic subjects with foot ulcer
54 diabetic subjects presenting foot ulcer will answer to the SF-36 score (mental health items) and to a french precarit index (EPICES:Evaluation de la précarité et des inégalités de santé dans les Centres d'examens de santé)
|
Subjects will pass the SF-36 score (mental health items) and the EPICES index
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare the levels of quality of life in diabetic subjects with and without foot ulcer
Time Frame: 6 months
|
The primary endpoint will be the score on the mental health dimension of the SF-36 score
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare the levels of precarity in diabetic subjects with and without foot ulcer
Time Frame: 6 months
|
To evaluate the level of precarity, the EPICES score will be calculated for both type of subjects.
|
6 months
|
|
Compare the levels of quality of life according to the levels of HbA1c, in diabetic subjects with and without foot ulcer
Time Frame: 6 months
|
To evaluate the level of quality of life according to HbA1c, the score of the mental health dimension of the SF-36 questionnaire will be calculated for both type of subjects.
|
6 months
|
|
Compare the quality of life levels according to the duration of diabetes, in diabetic subjects with and without foot ulcer
Time Frame: 6 months
|
To evaluate the level of quality of life according to the duration of diabetes, the score of the mental health dimension of the SF-36 questionnaire will be calculated for both type of subjects.
|
6 months
|
|
Compare the quality of life levels according to the type of antidiabetic treatment, in diabetic subjects with and without foot ulcer
Time Frame: 6 months
|
To evaluate the level of quality of life according to the antidiabetic treatment, the score of the mental health dimension of the SF-36 questionnaire will be calculated for both type of subjects.
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Miguel BOURGADE, MD, University Hospital Center of Martinique
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Glucose Metabolism Disorders
- Metabolic Diseases
- Skin Diseases
- Endocrine System Diseases
- Diabetic Angiopathies
- Leg Ulcer
- Skin Ulcer
- Diabetic Neuropathies
- Foot Diseases
- Diabetes Mellitus
- Diabetic Foot
- Foot Ulcer
- Ulcer
- Diabetes Complications
Other Study ID Numbers
- 21_RIPH3-04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.